Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Research and development spending
3Y CAGR
+0.6%/yr
vs +31.1%/yr prior
5Y CAGR
+8.3%/yr
Recent deceleration
Acceleration
-30.5pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $300.27M | +6.4% |
| 2024 | $282.34M | -17.9% |
| 2023 | $344.08M | +16.7% |
| 2022 | $294.78M | +13.8% |
| 2021 | $259.04M | +28.4% |
| 2020 | $201.73M | +21.5% |
| 2019 | $166.02M | +66.3% |
| 2018 | $99.83M | +39.4% |
| 2017 | $71.61M | +155.4% |
| 2016 | $28.04M | - |